not biosimilar products. different 'drugs'.
lock up the adult markets then pivot to pediatrics and the lesser indications. your comments over here suggest your're very insecure.
Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata, page-17
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 352684 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 54843 | 3 |
View Market Depth
| Last trade - 10.34am 17/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable